HRMY - Harmony Biosciences Holdings, Inc.
NEXT EARNINGS:
Feb 24, 2026
(today)
EPS Est: $0.84
|
Rev Est: $240.3M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$48.17
DETAILS
HIGH:
$62.00
LOW:
$31.00
MEDIAN:
$48.00
CONSENSUS:
$48.17
UPSIDE:
70.88%
Market Cap:
1.62B
Volume:
2,950,326
Avg Volume:
752,823
52 Week Range:
25.52-40.87
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.84
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
268
IPO Date:
2020-08-19
EPS (TTM):
2.76
P/E Ratio:
13.56
Revenue (TTM):
868.45M
Total Assets:
1.27B
Total Debt:
20.00M
Cash & Equiv:
752.50M
Rev Growth (5Y):
40.3%
EPS Growth (5Y):
62.2%
FCF Growth (5Y):
N/A
ROCE:
N/A
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $0.87 | $0.92 | -5.4% | $239.5M | $240.0M | -0.2% |
| 2025-08-05 | $0.68 | $0.78 | -12.8% | $200.5M | $220.2M | -8.9% |
| 2025-05-06 | $0.78 | $0.59 | +32.2% | $184.7M | $206.1M | -10.3% |
| 2025-02-25 | $0.85 | $0.74 | +14.9% | $201.3M | $183.2M | +9.9% |
| 2024-10-29 | $0.79 | $0.67 | +17.9% | $186.0M | $198.6M | -6.3% |
| 2024-08-06 | $0.20 | $-0.06 | +433.3% | $172.8M | $173.1M | -0.2% |
| 2024-04-30 | $0.67 | $0.60 | +11.7% | $154.6M | $154.7M | 0.0% |
| 2024-02-22 | $0.45 | $0.48 | -6.2% | $168.4M | $169.7M | -0.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 868.45M | 714.73M | 582.02M | 437.86M | 305.44M | 159.74M | 6.00M | 0 |
| Net Income | 158.69M | 145.49M | 128.85M | 181.47M | 34.60M | (36.94M) | (151.98M) | (39.90M) |
| EPS | 2.76 | 2.56 | 2.17 | 3.07 | 0.60 | -1.12 | -2.94 | -1.42 |
| Total Assets | 1.27B | 999.20M | 811.45M | 673.87M | 433.44M | 427.07M | 106.70M | 89.28M |
| Total Debt | 20.00M | 181.41M | 193.57M | 191.65M | 195.74M | 194.25M | 97.95M | 324.20M |
| Cash & Equivalents | 752.50M | 453.00M | 311.66M | 243.78M | 234.31M | 228.63M | 24.46M | 83.52M |
| Operating Cash Flow | 0 | 219.82M | 219.39M | 144.47M | 98.56M | (2.98M) | (75.44M) | (38.80M) |
| Free Cash Flow | 0 | 218.67M | 219.07M | 144.29M | 98.26M | (4.99M) | (75.58M) | (40.14M) |
| FCF per Share | N/A | 3.84 | 3.68 | 2.44 | 1.71 | -0.09 | -1.19 | -0.82 |
| Book Value | 870.22M | 659.15M | 466.99M | 402.84M | 186.51M | 97.18M | (11.59M) | 81.53M |
| Cash & ST Investments | 752.50M | 467.19M | 353.46M | 323.12M | 234.31M | 228.63M | 24.46M | 83.52M |
| ROC Equity | 0.18 | 0.22 | 0.28 | 0.45 | 0.19 | -0.38 | N/A | -0.49 |